发明名称 Methods of inhibiting activation of complement component C4 with anti-C1s antibodies
摘要 The present disclosure provides antibodies that bind complement C1s protein; and nucleic acid molecules that encode such antibodies. The present disclosure also provides compositions comprising such antibodies, and methods to produce and use such antibodies, nucleic acid molecules, and compositions.
申请公布号 US9074004(B2) 申请公布日期 2015.07.07
申请号 US201414523093 申请日期 2014.10.24
申请人 TRUE NORTH THERAPEUTICS, INC. 发明人 Van Vlasselaer Peter;Parry Graham;Stagliano Nancy E.;Panicker Sandip
分类号 A61K39/395;C07K16/40;A61K39/00 主分类号 A61K39/395
代理机构 Bozicevic, Field & Francis LLP 代理人 Bozicevic, Field & Francis LLP ;Borden Paula A.
主权项 1. A method of inhibiting activation of complement component C4 in an individual in need thereof, the method comprising administering to the individual a pharmaceutical composition comprising: a pharmaceutically acceptable excipient suitable for administration to a human; and a humanized antibody that binds complement C1s protein and comprises light chain complementarity determining regions (CDRs) of an antibody light chain variable region comprising amino acid sequence SEQ ID NO:7 and heavy chain CDRs of an antibody heavy chain variable region comprising amino acid sequence SEQ ID NO:8.
地址 South San Francisco CA US